Invest Now
Samco securities limited
Samco Star Rating Ads

Jubilant Pharmova Ltd

₹ 1,177.40 +13.75 (1.18%)

Updated on 10-10-2024 4:42 PM

Stock Rating

Pros 2

 

Cons 7

Price Performance

  • Day's Low
  • ₹1,158.20
  • Day's High
  • ₹1,192.65
₹ 1,177.40
  • 52-w low
  • ₹318.75
  • 52-w high
  • ₹1,247.15
1,177.40
  • Day's open
    ₹1,173.50
  • Previous close
    ₹1,163.65
  • VWAP
    ₹1,179.34
  • Lower price band
    ₹930.95
  • Upper price band
    ₹1,396.35

Today's Market Action

The last traded share price of Jubilant Pharmova Ltd was 1,177.40 up by 1.18% on the NSE. Its last traded stock price on BSE was 1,183.80 up by 1.64%. The total volume of shares on NSE and BSE combined was 194,040 shares. Its total combined turnover was Rs 22.89 crores.

Medium and Long Term Market Action

Jubilant Pharmova Ltd hit a 52-week high of 1,247.15 on 16-09-2024 and a 52-week low of 318.75 on 26-10-2023. The stock price of Jubilant Pharmova Ltd is up by 16% over the last one month. It is up by 177.62% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 18139

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Jubilant Pharmova Ltd?

What is the Market Cap of Jubilant Pharmova Ltd?

What is PE Ratio of Jubilant Pharmova Ltd?

What is PB Ratio of Jubilant Pharmova Ltd?

What is the CAGR of Jubilant Pharmova Ltd?

How to Buy Jubilant Pharmova Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 117.84% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 3.31 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.92. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 122 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(11/10/2024)
Stock Valuation
Red line
80
100.00%
100.00% People are bullish about Jubilant Pharmova Ltd
0.00%
0.00 % People are bearish about Jubilant Pharmova Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Jubilant Pharmova Ltd

₹ 1,177.40 +13.75 (1.18%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon